Barbara J Winslow

This inventor holds 9 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Schering-Plough Animal Health Corporation, Texas A&M University System, Intervet Inc.. Active years: 2001-2012.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 55.6

EPO Patents = 2

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

San Rafael, CA (US) (2011)
Delmar, CA (US) (2001 - 2012)

Company Filing History:

4 out of 30

Schering-Plough Animal Health Corporation

patents

4 out of 1,327

Texas A&M University System

Schering-Plough Veterinary Corporation

patents

where one patent can have more than one assignee

Years Active: 2001-2012

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8188236 - Eta-1 gene and methods for use (2012-05-29),

2. 8071738 - Feline CD86 polypeptides and nucleic acids (2011-12-06),

3. 7780965 - Eta-1 gene and methods for use (2010-08-24),

4. 7745593 - Feline CTLA-4 nucleic acid and polypeptides (2010-06-29),

5. 7279168 - Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof (2007-10-09),

6. 7205398 - Eta-1 gene and methods for use (2007-04-17),

7. 7078512 - Nucleic acid encoding feline CD86 (2006-07-18),

8. 6410311 - Recombinant feline herpesvirus comprising a foreign DNA inserted into a region corresponding to a 3.0 kb EcoRI-SalI fragment of a feline herpesvirus genome (2002-06-25),

9. 6183753 - Recombinant chimeric virus and uses thereof (2001-02-06),

I specialize in the sphere of innovations, inventions, inventors, patent attorneys, assignees, and patents. Here is the article about inventor Barbara J Winslow based on the given data:

Title: Innovator Spotlight: Barbara J Winslow

Introduction:

Barbara J Winslow is a pioneering inventor based in Del Mar, CA, with a remarkable portfolio of 9 patents to her name. Her innovative spirit and dedication to advancing science have led to groundbreaking discoveries in the field of immunology and vaccine development.

Latest Patents:

Barbara J Winslow's latest patents include the Eta-1 gene and methods for use. This invention focuses on enhancing immune responses in animals by utilizing osteopontin (Eta-1) polypeptides and nucleic acids. Additionally, she has patented feline CD86 polypeptides and nucleic acids, which play a crucial role in vaccine development for felines, enhancing immune responses and suppressing immune reactions.

Career Highlights:

Throughout her career, Barbara J Winslow has made significant contributions to the scientific community. She has worked with esteemed companies such as Schering-Plough Animal Health Corporation and The Texas A&M University System, where she has honed her expertise in molecular biology and vaccine research. Winslow's dedication to innovation has earned her a reputation as a leading figure in the field of biotechnology.

Collaborations:

Barbara J Winslow has collaborated with talented individuals in her field, including Mark D Cochran and Ellen W Collisson. Together, they have worked on cutting-edge research projects and have contributed to the development of novel vaccines and immunotherapies.

Conclusion:

Barbara J Winslow's inventive spirit and commitment to scientific progress have positioned her as a trailblazer in the field of biotechnology. Her patents and research efforts have had a profound impact on the development of vaccines and immunotherapies, paving the way for advancements in animal health and immunology. Barbara J Winslow's legacy as an innovative inventor continues to inspire future generations of scientists and researchers.